In 2019, the FDA categorized psilocybin therapy being a breakthrough therapy for 2 scientific trials investigating the consequences of it on critical melancholy and main depressive disorder.This species is characterised by its golden cap and deep black-colored spores. It’s mainly located in Cambodia and various elements of tropical Asia, together